GF
Gries Financial’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
49,656
+676
| +1% | +$31.3K | 0.42% | 49 |
|
|
2025
Q1 | $2.99M | Sell |
48,980
-2,267
| -4% | -$138K | 0.58% | 33 |
|
|
2024
Q4 | $2.9M | Buy |
51,247
+33,832
| +194% | +$1.91M | 0.51% | 37 |
|
|
2024
Q3 | $901K | Buy |
17,415
+267
| +2% | +$13.8K | 0.17% | 131 |
|
|
2024
Q2 | $712K | Sell |
17,148
-50,969
| -75% | -$2.12M | 0.15% | 128 |
|
|
2024
Q1 | $3.69M | Buy |
68,117
+26,338
| +63% | +$1.43M | 0.62% | 35 |
|
|
2023
Q4 | $2.14M | Sell |
41,779
-1,332
| -3% | -$68.3K | 0.47% | 52 |
|
|
2023
Q3 | $2.5M | Sell |
43,111
-728
| -2% | -$42.3K | 0.67% | 31 |
|
|
2023
Q2 | $2.8M | Sell |
43,839
-448
| -1% | -$28.7K | 0.77% | 26 |
|
|
2023
Q1 | $3.07M | Sell |
44,287
-1,949
| -4% | -$135K | 0.91% | 21 |
|
|
2022
Q4 | $3.33M | Buy |
46,236
+8,911
| +24% | +$641K | 1.1% | 18 |
|
|
2022
Q3 | $2.65M | Buy |
37,325
+707
| +2% | +$50.3K | 1.12% | 18 |
|
|
2022
Q2 | $2.82M | Sell |
36,618
-10,114
| -22% | -$779K | 1.34% | 15 |
|
|
2022
Q1 | $3.41M | Buy |
46,732
+9,300
| +25% | +$679K | 1.26% | 13 |
|
|
2021
Q4 | $2.33M | Buy |
37,432
+18,427
| +97% | +$1.15M | 0.95% | 20 |
|
|
2021
Q3 | $1.13M | Sell |
19,005
-150
| -0.8% | -$8.88K | 0.35% | 81 |
|
|
2021
Q2 | $1.31M | Hold |
19,155
| – | – | 0.42% | 67 |
|
|
2021
Q1 | $1.25M | Buy |
+19,155
| New | +$1.25M | 0.4% | 72 |
|